PUBLISHER: TechSci Research | PRODUCT CODE: 1068574
PUBLISHER: TechSci Research | PRODUCT CODE: 1068574
We offer 8 hour analyst time for an additional research. Please contact us for the details.
Global head and neck cancer therapeutics market value in 2021 was USD2024.33 million, which is expected to grow further with a CAGR of 7.22% during the forecast period, 2023-2027, to achieve the market value of USD3126.26 million by 2027F. This impressive growth of the market can be attributed to the advancing healthcare industry, majorly the therapeutics sector for cancer treatments. Increasing instances of cancer like head cancer, throat cancer further drive the growth of the global head and neck cancer therapeutics market in the upcoming five years. Additionally, the market is also bound to experience growth due to advancements in the pharmaceutical industry. Precision medicine is highly implemented when cancer therapeutics are involved. The popularity of precision medicine, along with its specificity toward the cancer treatment of the respective patient being based on the type of cancer along with genetic information from the patient, enhances the success rates of the procedure, therefore, supporting the growth of the global head and neck cancer therapeutics market in the next five years. Increased consumption of tobacco and tobacco-based products, rapidly increasing smoking habits, and alcohol consumption among the population is also contributing to the increasing cases of throat cancer, which leads to the growth of the global head and neck cancer therapeutics market in the future five years.
The global head and neck cancer therapeutics market is majorly segmented by type, end user, regional distribution, and competition. By type, the market is differentiated into diagnostic methods and treatment type, where segments of the treatment type market are further analyzed by disease indication, route of administration, and therapeutic class. Diagnostic methods are forecast to dominate the market by holding the largest revenue shares of the market in the upcoming five years due to increasing demand for the early and efficient diagnosis of patients suffering from cancer. Treatment for the early stages of cancer is rather feasible and has a higher success rate; therefore, the demand for diagnosing cancer at its early stage drives the growth of the segment along with the growth of the global head and neck cancer therapeutics market in the next five years.
Treatment type segment is forecast to advance in the next five years and account for a share of over 41% in 2027 on the grounds of increasing advancement in the pharmaceutical and therapeutic sector. Surging demand for effective treatment for growing instances of cancer further aids the market growth.
Major companies in the global head and neck cancer therapeutics market are Eli Lilly and Company, Bristol Myers Squibb Company, Sanofi S.A., Merck & Co., Inc., Pfizer Inc, AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, AstraZeneca Plc., Astellas Pharma Inc., AB Science SA, Boston Biomedical, Inc., among others.
Years considered for this report:
Historical Years: 2017- 2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023 - 2027
Objective of the Study:
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers & service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers & service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers & service providers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of global head and neck cancer therapeutics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products & services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, service providers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global head and neck cancer therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Diagnostic Methods
Treatment Type
Lip and Oral Cavity Cancer
Laryngeal Cancer
Oropharyngeal Cancer
Salivary Gland Cancer
Nasopharyngeal Cancer
Hypopharyngeal Cancer
Injectable
Oral
PD Inhibitors
EGFR Inhibitors
Microtubule Inhibitors
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others
North America
Europe
Asia Pacific
South America
Middle East & Africa
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global head and neck cancer therapeutics market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information